THE NEW REGULATIONS FOR THE APPROVAL OF MEDICINAL PRODUCTS IN IVORY COAST: APPLICATION OF REGULATION N ° 06/2010 / CM / WAEMU RELATING TO PROCEDURES FOR THE APPROVAL OF PHARMACEUTICAL PRODUCTS FOR HUMAN USE IN WAEMU MEMBER STATES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 4
Abstract
Harmonization of procedures for the approval of medicines in the WAEMU area allows Member States to have a standard tool for the examination of applications for marketing authorization for medicinal products for human use. The objective of this study was to highlight the textual provisions adopted by a member state, Côte d'Ivoire for optimal application of the Community norm. The methodology used consisted, on the basis of a reminder of the main points of Regulation No. 06 / CM / UEMOA concerning the approval of medicinal products for human use, to show how the national implementing decrees taken in Côte d'Ivoire the Regulation. However, the need for Member States to act more expeditiously with regard to the application of Community standards is clear.
Authors and Affiliations
Amari ASG, Aka A, Pabst J Y
Keywords
Related Articles
- EP ID EP329053
- DOI 10.22270/ijdra.v5i4.204
- Views 144
- Downloads 0
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DILTIAZEM HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP- HPLC
A simple, specific, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the estimation of Diltiazem Hydrochloride in bulk and pharmaceutical dosage f...
FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS
Aim of present research work was formulation and development of bilayer tablets of Ketoprofen to reduce the side effects of Ketoprofen and to improve the therapeutic benefits and patients’ compliance to treatment. Bi-lay...
COMPARATIVE STUDY OF REGULATORY REQUIREMENTS AND REGISTRATION PROCESS OF GENERIC DRUGS IN JAPAN AND CHINA
A Generic Product must meet the standards established by Pharmaceutical Medical Device Agency (PMDA) & China Food and Drug Administration (CFDA) to be approved for marketing in Japan and China respectively. This study co...
COMMON DEFICIENCIES RAISED BY VARIOUS REGULATORY AGENCIES
Timely Product registration is a challenge in today’s scenario. Regulatory agencies are keen in assessing CTD sections like redefining starting material of Drug substance manufacturing, Pharmaceutical development, impuri...
Differentiation between the Regulatory paths placed on Mouthwashes in the US and EU
Regulating oral rinses has been and still is a topic of debate and confusion. Oral rinses are products that are mainly used for cleaning, perfuming and changing the appearance of the teeth, which in turn improves the ind...